IDEAYA BIOSCIENCES, INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$219M
R&D
$315M
D&A
$3M
Operating Income
$-159M
EBITDA
$-157M
Interest Income
—
Tax Provision
$0
Net Income
$-114M
Operating Margin
-72.8%
Net Margin
-52.0%
Deferred Tax Assets
$5M
Deferred Tax Liabilities
$62K
DTA Valuation Allowance
$196M
Tax Credit Carryforwards
$47M
NOL Carryforwards
$37M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
1.5%
Operating Lease Cost
$5M
Revenue YoY Variation
3024.4%
Income YoY Variation
51.3%